Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 1,806,829	$ 1,192,230
Trade accounts receivable, less allowance for credit losses (2025 – $5,189; 2024 – $5,201)	766,433	742,201
Other accounts receivable	113,305	238,384
Inventories	1,640,925	1,502,531
Other current assets	177,695	166,916
Total current assets	4,505,187	3,842,262
Property, plant and equipment, at cost	12,792,572	12,523,368
Less accumulated depreciation and amortization	3,539,678	3,191,898
Net property, plant and equipment	9,252,894	9,331,470
Investments	890,384	1,117,739
Other assets	737,587	504,711
Goodwill	1,670,927	1,582,714
Other intangibles, net of amortization	234,948	230,753
Total assets	17,291,927	16,609,649
Current liabilities:
Accrued expenses	414,884	467,997
Current portion of long-term debt	444,911	398,023
Dividends payable	61,331	61,282
Income taxes payable	169,877	95,275
Total current liabilities	1,949,784	1,966,464
Long-term debt	3,178,111	3,118,142
Postretirement benefits	32,103	31,930
Pension benefits	121,638	116,192
Other noncurrent liabilities	1,144,798	819,204
Deferred income taxes	366,509	358,029
Commitments and contingencies (Note 7)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, authorized – 275,000, issued and outstanding – 117,669 in 2025 and 117,560 in 2024	1,177	1,176
Mandatory convertible preferred stock, Series A, no par value, $1,000 stated value, authorized – 15,000, issued and outstanding – 2,300 in 2025 and 2024	2,235,105	2,235,105
Additional paid-in capital	3,001,531	2,985,606
Accumulated other comprehensive loss	(364,544)	(742,062)
Retained earnings	5,367,257	5,481,692
Total Albemarle Corporation shareholders’ equity	10,240,526	9,961,517
Noncontrolling interests	258,458	238,171
Total equity	10,498,984	10,199,688
Total liabilities and equity	17,291,927	16,609,649
Nonrelated Party
Current liabilities:
Accounts payable	737,317	793,455
Related Party
Current liabilities:
Accounts payable	$ 121,464	$ 150,432